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We read with great interest the contribution by 
Muscal et al.1 They reported the development of systemic 
autoimmunity such as systemic lupus erythematosus (SLE) 
and antiphospholipid antibodies in children with acquired 
thrombotic thrombocytopenic purpura (TTP). We would 
like to suggest some potential pathologic mechanisms on the 
development of concurrent SLE in relation to TTP.
Kakishita2 found that TTP after bone marrow 
transplantation (BMT) could be predicted at an early stage 
by an increase in the level of plasma interleukin (IL)-12, 
postulating that TTP might be related to inflammation 
or autoimmunity. According to an animal experiment by 
Nakajima et al,3 transfer of IL-12–stimulated splenocytes 
from 5-month-old B/W F1 mice to B/W F1 mice of the 
same age enhanced the production of IgG anti-dsDNA 
antibody, indicating that IL-12 serves a key role in the 
complexity of cytokine regulation in the pathogenesis of 
SLE autoimmunity. In another animal model by Huang 
et al,4 MRL/MP-lpr/lpr (MRL/lpr) mice, developing a 
spontaneous autoimmune disease, also produced markedly 
higher concentrations of IL-12 than age-matched MRL/
lpr+ or BALB/c mice, and daily injection of IL-12 increased 
serum levels of interferon γ (IFN-γ) and accelerated 
glomerulonephritis in the young MRL/lpr mice.
Recently, Tucci et al5 demonstrated that higher serum 
IL-12 levels in SLE were associated with lupus nephritis, and 
a T helper 1 (TH1) phenotype with high IFN-γ expression 
was correlated in parallel with the severity of renal damage. 
Shah et al6 also reported that increased levels of IL-12 and 
IFN-γ were found in the culture supernatant of peripheral 
blood mononuclear cells of patients with SLE and positively 
correlated with the Systemic Lupus Erythematosus Disease 
Activity Index.
Therefore, there is a possibility that TH1-derived 
cytokines, such as IL-12 and IFN-γ, might fulfill a critical 
role in the development of SLE in children, particularly 
children with TTP. However, further studies are necessary to 
elucidate the exact signaling transduction pathway of IL-12 
and IFN-γ and the subset of TH cells that is more prevalent 
in the disease process. The role of IL-21, a member of the 
type I cytokine superfamily, and IL-17, produced by CD4+/
CD45RO+ memory T cells, in autoimmunity should also be 
further evaluated.
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